Published in TB and Outbreaks Week, November 15th, 1999
Data presented included the clinical outcomes of patients receiving Synagis during the 1998/1999 RSV season, the drug's first season of general use in the United States. Also presented were data from an Expanded Access Study in 15 countries where Synagis was not yet available during the 1998/1999 season.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.